Company · CIK 0001516551 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Skye Bioscience, Inc. · SKYE
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2026 SForm 4 → | Sep 24, 4:31 pm EDT | Andrew J. SchwabDirector, 10% Owner | 148,079 | $1.62 | $239,555 | 0 | −100% | |
| Sep 22, 2026 SForm 4 → | Sep 24, 4:29 pm EDT | 5AM Partners VII, LLC +710% Owner | 148,079 | $1.62 | $239,555 | 0 | −100% | |
| Sep 16, 2026 SForm 4 → | Sep 18, 6:39 pm EDT | Andrew J. SchwabDirector, 10% Owner | 33,892 | $1.91 | $64,734 | 5,616 | −85.8% | |
| Sep 16, 2026 SForm 4 → | Sep 18, 6:37 pm EDT | 5AM Partners VII, LLC +710% Owner | 33,892 | $1.91 | $64,734 | 5,616 | −85.8% | |
| Aug 18, 2026 SForm 4 → | Aug 20, 5:59 pm EDT | Andrew J. SchwabDirector, 10% Owner | 375,840 | $0.3733 | $140,313 | 7,850,155 | −4.57% | |
| Aug 18, 2026 SForm 4 → | Aug 20, 5:57 pm EDT | 5AM Partners VII, LLC +710% Owner | 375,840 | $0.3733 | $140,313 | 7,850,155 | −4.57% | |
| Aug 7, 2026 AForm 4 → | Aug 7, 5:37 pm EDT | Punit DhillonChief Executive Officer, Director | 1,090,000 | — | — | 1,419,823 | — |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.